{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:39:40Z","timestamp":1787002780167,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371978"],"award-info":[{"award-number":["82371978"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302212"],"award-info":[{"award-number":["82302212"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071945"],"award-info":[{"award-number":["82071945"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82227803"],"award-info":[{"award-number":["82227803"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In clinical practice, triple-negative breast cancer (TNBC) patients with varying levels of lipid metabolism exhibit differences in tumor shear-wave elastography (SWE) stiffness and prognosis, but this association with unclear mechanism. In this study, a clinical cohort from FUSCC (n\u2009=\u2009147) demonstrated that both elevated BMI and higher SWE stiffness were significantly associated with poorer long-term prognosis in TNBC patients, and these associations were further validated in multi-TNBC animal models. Our findings emphasize the role of SWE stiffness in capturing BMI-related alterations in the tumor mechanical microenvironment. Based on integrated lipidomic and transcriptomic analyses, we demonstrated that diacylglycerol (DAG) serves as a critical lipid molecule promoting elevated SWE stiffness and malignant progression. Mechanistically, DAG upregulates TGF-\u03b21 expression through PKC-mediated enhancement of CREB1 phosphorylation in multiple TNBC cell lines, directly promoting TNBC progression and activating cancer-associated fibroblasts. This creates a self-sustaining feedback loop that accelerates malignancy. Finally, we confirmed that the DAG\/PKC\/CREB1\/TGF-\u03b21 signaling axis profoundly regulates SWE imaging stiffness in TNBC models, with further validation in clinical samples. Our study establishes SWE stiffness as a non-invasive imaging biomarker for the activation of this specific pro-metastatic pathway, providing a mechanistic basis for interpreting SWE features through a biological lens and paving the way for its application in prognosis prediction and tailored therapeutic strategies for high-risk TNBC patients.<\/jats:p>","DOI":"10.1038\/s41419-026-08625-0","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T14:45:27Z","timestamp":1774017927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The DAG\/PKC\/CREB1\/TGF-\u03b21 axis drives shear-wave elastography stiffness and malignant progression in triple-negative breast cancer via lipid metabolic reprogramming"],"prefix":"10.1038","volume":"17","author":[{"given":"Shiyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6189-9046","authenticated-orcid":false,"given":"Dongdong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoqing","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanping","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1996-9041","authenticated-orcid":false,"given":"Shichong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"8625_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01944-w","volume":"23","author":"C Zhang","year":"2024","unstructured":"Zhang C, Yu Z, Yang S, Liu Y, Song J, Mao J, et al. ZNF460-mediated circRPPH1 promotes TNBC progression through ITGA5-induced FAK\/PI3K\/AKT activation in a ceRNA manner. Mol Cancer. 2024;23:33.","journal-title":"Mol Cancer"},{"key":"8625_CR2","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.annonc.2024.02.002","volume":"35","author":"L Pusztai","year":"2024","unstructured":"Pusztai L, Denkert C, O'Shaughnessy J, Cortes J, Dent R, McArthur H, et al. Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522. Ann Oncol. 2024;35:429\u201336.","journal-title":"Ann Oncol"},{"key":"8625_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13045-022-01345-w","volume":"15","author":"X Wang","year":"2022","unstructured":"Wang X, Chen T, Li C, Li W, Zhou X, Li Y, et al. CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR. J Hematol Oncol. 2022;15:122.","journal-title":"J Hematol Oncol"},{"key":"8625_CR4","doi-asserted-by":"publisher","first-page":"155744","DOI":"10.1016\/j.metabol.2023.155744","volume":"152","author":"DJH Tan","year":"2024","unstructured":"Tan DJH, Ng CH, Muthiah M, Yong JN, Chee D, Teng M, et al. Rising global burden of cancer attributable to high BMI from 2010 to 2019. Metabolism. 2024;152:155744.","journal-title":"Metabolism"},{"key":"8625_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40164-025-00647-2","volume":"14","author":"M Zhang","year":"2025","unstructured":"Zhang M, Zhang B. Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer. Exp Hematol Oncol. 2025;14:54.","journal-title":"Exp Hematol Oncol"},{"key":"8625_CR6","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.ultrasmedbio.2020.02.012","volume":"46","author":"LT Xie","year":"2020","unstructured":"Xie LT, Gu JH, Chai WL, Chen RD, Zhao QY, Kong DX, et al. Pre-operative detection of liver fibrosis in hepatocellular carcinoma patients using 2D shear wave elastography: where to measure? Ultrasound Med Biol. 2020;46:1412\u201323.","journal-title":"Ultrasound Med Biol"},{"key":"8625_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00325-6","volume":"7","author":"S Harborg","year":"2021","unstructured":"Harborg S, Zachariae R, Olsen J, Johannsen M, Cronin-Fenton D, B\u00f8ggild H, et al. Overweight and prognosis in triple-negative breast cancer patients: a systematic review and meta-analysis. NPJ Breast Cancer. 2021;7:119.","journal-title":"NPJ Breast Cancer"},{"key":"8625_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19694-w","volume":"11","author":"L Song","year":"2020","unstructured":"Song L, Liu Z, Hu HH, Yang Y, Li TY, Lin ZZ, et al. Proto-oncogene Src links lipogenesis via lipin-1 to breast cancer malignancy. Nat Commun. 2020;11:5842.","journal-title":"Nat Commun"},{"key":"8625_CR9","doi-asserted-by":"publisher","first-page":"0264","DOI":"10.1126\/scisignal.abo0264","volume":"15","author":"M Cooke","year":"2022","unstructured":"Cooke M, Kazanietz MG. Overarching roles of diacylglycerol signaling in cancer development and antitumor immunity. Sci Signal. 2022;15:0264.","journal-title":"Sci Signal"},{"key":"8625_CR10","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1002\/mc.22844","volume":"57","author":"C Huang","year":"2018","unstructured":"Huang C, Cao Z, Ma J, Shen Y, Bu Y, Khoshaba R, et al. AKR1B10 activates diacylglycerol (DAG) second messenger in breast cancer cells. Mol Carcinog. 2018;57:1300\u201310.","journal-title":"Mol Carcinog"},{"key":"8625_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/gutjnl-2020-322744","volume":"71","author":"X Sun","year":"2022","unstructured":"Sun X, He X, Zhang Y, Hosaka K, Andersson P, Wu J, et al. Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism. Gut. 2022;71:129\u201347.","journal-title":"Gut"},{"key":"8625_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2019","unstructured":"Chen X, Song E. Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov. 2019;18:99\u2013115.","journal-title":"Nat Rev Drug Discov"},{"key":"8625_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","volume":"33","author":"A Costa","year":"2018","unstructured":"Costa A, Kieffer Y, Scholer-Dahirel A, Pelon F, Bourachot B, Cardon M, et al. Fibroblast heterogeneity and immunosuppressive environment in human breast cancer. Cancer Cell. 2018;33:463\u201379.e10.","journal-title":"Cancer Cell"},{"key":"8625_CR14","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1101\/gad.279737.116","volume":"30","author":"P Gascard","year":"2016","unstructured":"Gascard P, Tlsty TD. Carcinoma-associated fibroblasts: orchestrating the composition of malignancy. Genes Dev. 2016;30:1002\u201319.","journal-title":"Genes Dev"},{"key":"8625_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s13046-021-02022-5","volume":"40","author":"P Hern\u00e1ndez-Camarero","year":"2021","unstructured":"Hern\u00e1ndez-Camarero P, L\u00f3pez-Ruiz E, Marchal JA, Per\u00e1n M. Cancer: a mirrored room between tumor bulk and tumor microenvironment. J Exp Clin Cancer Res. 2021;40:217.","journal-title":"J Exp Clin Cancer Res"},{"key":"8625_CR16","first-page":"567","volume":"22","author":"D Zheng","year":"2022","unstructured":"Zheng D, Zhou J, Qian L, Liu X, Chang C, Tang S, et al. Biomimetic nanoparticles drive the mechanism understanding of shear-wave elasticity stiffness in triple-negative breast cancers to predict clinical treatment. Bioact Mater. 2022;22:567\u201387.","journal-title":"Bioact Mater"},{"key":"8625_CR17","doi-asserted-by":"publisher","first-page":"2502617","DOI":"10.1002\/adma.202502617","volume":"37","author":"D Zheng","year":"2025","unstructured":"Zheng D, Yan J, Liu X, Zhang Z, Jin A, Zhao Y, et al. Artesunate nanoplatform targets the serine-MAPK axis in cancer-associated fibroblasts to reverse photothermal resistance in triple-negative breast cancer. Adv Mater. 2025;37:2502617.","journal-title":"Adv Mater"},{"key":"8625_CR18","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.3390\/ijms26083525","volume":"26","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Liang S, Zheng D, Wang S, Zhou J, Wang Z, et al. Using cancer-associated fibroblasts as a shear-wave elastography imaging biomarker to predict Anti-PD-1 efficacy of triple-negative breast cancer. Int J Mol Sci. 2025;26:3525.","journal-title":"Int J Mol Sci"},{"key":"8625_CR19","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s11547-024-01848-1","volume":"129","author":"JX Huang","year":"2024","unstructured":"Huang JX, Liu FT, Sun L, Ma C, Fu J, Wang XY, et al. Comparing shear wave elastography of breast tumors and axillary nodes in the axillary assessment after neoadjuvant chemotherapy in patients with node-positive breast cancer. Radiol Med. 2024;129:1143\u201355.","journal-title":"Radiol Med"},{"key":"8625_CR20","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1007\/s00330-013-2866-2","volume":"23","author":"JM Chang","year":"2013","unstructured":"Chang JM, Park IA, Lee SH, Kim WH, Bae MS, Koo HR, et al. Stiffness of tumours measured by shear-wave elastography correlated with subtypes of breast cancer. Eur Radiol. 2013;23:2450\u20138.","journal-title":"Eur Radiol"},{"key":"8625_CR21","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1093\/annonc\/mdu042","volume":"25","author":"DSM Chan","year":"2014","unstructured":"Chan DSM, Vieira AR, Aune D, Bandera EV, Greenwood DC, McTiernan A, et al. Body mass index and survival in women with breast cancer: systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol. 2014;25:1901\u201314.","journal-title":"Ann Oncol"},{"key":"8625_CR22","doi-asserted-by":"publisher","first-page":"14946","DOI":"10.1111\/jch.14946","volume":"27","author":"W Xiao","year":"2025","unstructured":"Xiao W, Han P, Song L, Yang J, Zhou L, Deng X, et al. A retrospective study to investigate the relationship between body mass index and hemodynamic characteristics in hypertensive patients. J Clin Hypertens. 2025;27:14946.","journal-title":"J Clin Hypertens"},{"key":"8625_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S2213-8587(21)00045-0","volume":"9","author":"XF Pan","year":"2021","unstructured":"Pan XF, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diab Endocrinol. 2021;9:373\u201392.","journal-title":"Lancet Diab Endocrinol"},{"key":"8625_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16199-4","volume":"11","author":"O Saatci","year":"2020","unstructured":"Saatci O, Kaymak A, Raza U, Ersan PG, Akbulut O, Banister CE, et al. Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple-negative breast cancer. Nat Commun. 2020;11:2416.","journal-title":"Nat Commun"},{"key":"8625_CR25","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/hep.26672","volume":"59","author":"AL Birkenfeld","year":"2014","unstructured":"Birkenfeld AL, Shulman GI. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology. 2014;59:713\u201323.","journal-title":"Hepatology"},{"key":"8625_CR26","doi-asserted-by":"publisher","first-page":"5396","DOI":"10.1038\/s41388-019-0796-4","volume":"38","author":"V Casado-Medrano","year":"2019","unstructured":"Casado-Medrano V, Barrio-Real L, Wang A, Cooke M, L\u00f3pez-Haber C, Kazanietz MG. Distinctive requirement of PKC\u03b5 in the control of Rho GTPases in epithelial and mesenchymally transformed lung cancer cells. Oncogene. 2019;38:5396\u2013412.","journal-title":"Oncogene"},{"key":"8625_CR27","doi-asserted-by":"publisher","first-page":"9960","DOI":"10.1126\/sciadv.aaw9960","volume":"6","author":"Y Qin","year":"2020","unstructured":"Qin Y, Chen W, Jiang G, Zhou L, Yang X, Li H, et al. Interfering with MSN-NONO complex-activated CREB signaling serves as a therapeutic strategy for triple-negative breast cancer. Sci Adv. 2020;6:9960.","journal-title":"Sci Adv"},{"key":"8625_CR28","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1158\/1078-0432.CCR-15-1275","volume":"22","author":"Y Kang","year":"2016","unstructured":"Kang Y, Nagaraja AS, Armaiz-Pena GN, Dorniak PL, Hu W, Rupaimoole R, et al. Adrenergic stimulation of DUSP1 impairs chemotherapy response in ovarian cancer. Clin Cancer Res. 2016;22:1713\u201324.","journal-title":"Clin Cancer Res"},{"key":"8625_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-022-01403-1","volume":"23","author":"R Tian","year":"2022","unstructured":"Tian R, Zhang Y, Pan Q, Wang Y, Wen Q, Fan X, et al. Calcitonin gene-related peptide receptor antagonist BIBN4096BS regulates synaptic transmission in the vestibular nucleus and improves vestibular function via the PKC\/ERK\/CREB pathway in an experimental chronic migraine rat model. J Headache Pain. 2022;23:35.","journal-title":"J Headache Pain"},{"key":"8625_CR30","doi-asserted-by":"publisher","first-page":"eabq1395","DOI":"10.1126\/sciadv.abq1395","volume":"9","author":"S Chen","year":"2023","unstructured":"Chen S, Shao F, Zeng J, Guo S, Wang L, Sun H, et al. Cullin-5 deficiency orchestrates the tumor microenvironment to promote mammary tumor development through CREB1-CCL2 signaling. Sci Adv. 2023;9:eabq1395.","journal-title":"Sci Adv"},{"key":"8625_CR31","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.7150\/ijbs.36854","volume":"15","author":"PC Hu","year":"2019","unstructured":"Hu PC, Li K, Tian YH, Pan WT, Wang Y, Xu XL, et al. CREB1\/Lin28\/miR-638\/VASP interactive network drives the development of breast cancer. Int J Biol Sci. 2019;15:2733\u201349.","journal-title":"Int J Biol Sci"},{"key":"8625_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41392-023-01487-4","volume":"8","author":"B He","year":"2023","unstructured":"He B, Gao R, Lv S, Chen A, Huang J, Wang L, et al. Cancer cells employ a microenvironmental neural signal transactivating nucleus-mitochondria coordination to acquire stemness. Signal Transduct Target Ther. 2023;8:275.","journal-title":"Signal Transduct Target Ther"},{"key":"8625_CR33","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.ccell.2024.03.005","volume":"42","author":"N Niu","year":"2024","unstructured":"Niu N, Shen X, Wang Z, Chen Y, Weng Y, Yu F, et al. Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer. Cancer Cell. 2024;42:869\u201384.e9.","journal-title":"Cancer Cell"},{"key":"8625_CR34","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1158\/2159-8290.CD-22-1467","volume":"13","author":"WH Hsu","year":"2023","unstructured":"Hsu WH, LaBella KA, Lin Y, Xu P, Lee R, Hsieh CE, et al. Oncogenic KRAS drives lipofibrogenesis to promote angiogenesis and colon cancer progression. Cancer Discov. 2023;13:2652\u201373.","journal-title":"Cancer Discov"},{"key":"8625_CR35","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/jum.16192","volume":"42","author":"R Togawa","year":"2023","unstructured":"Togawa R, Pfob A, B\u00fcsch C, Alwafai Z, Balleyguier C, Clevert DA, et al. Potential of lesion-to-fat elasticity ratio measured by shear wave elastography to reduce benign biopsies in BI-RADS 4 breast lesions. J Ultrasound Med. 2023;42:1729\u201336.","journal-title":"J Ultrasound Med"},{"key":"8625_CR36","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.3390\/diagnostics13203178","volume":"13","author":"S Wang","year":"2023","unstructured":"Wang S, Lan Z, Wan X, Liu J, Wen W, Peng Y. Correlation between baseline conventional ultrasounds, shear-wave elastography indicators, and neoadjuvant therapy efficacy in triple-negative breast cancer. Diagnostics. 2023;13:3178.","journal-title":"Diagnostics"},{"key":"8625_CR37","doi-asserted-by":"publisher","first-page":"S376","DOI":"10.1245\/s10434-015-4828-1","volume":"22","author":"SH Lee","year":"2015","unstructured":"Lee SH, Chang JM, Han W, Moon HG, Koo HR, Gweon HM, et al. Shear-wave elastography for the detection of residual breast cancer after neoadjuvant chemotherapy. Ann Surg Oncol. 2015;22:S376\u2013S84.","journal-title":"Ann Surg Oncol"},{"key":"8625_CR38","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13244-024-01747-z","volume":"15","author":"R Togawa","year":"2024","unstructured":"Togawa R, Riedel F, Feisst M, Fastner S, Gomez C, Hennigs A, et al. Shear-wave elastography as a supplementary tool for axillary staging in patients undergoing breast cancer diagnosis. Insights Imaging. 2024;15:196.","journal-title":"Insights Imaging"},{"key":"8625_CR39","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10549-022-06804-z","volume":"197","author":"J Li","year":"2023","unstructured":"Li J, Sun B, Li Y, Li S, Wang J, Zhu Y, et al. Correlation analysis between shear-wave elastography and pathological profiles in breast cancer. Breast Cancer Res Treat. 2023;197:269\u201376.","journal-title":"Breast Cancer Res Treat"},{"key":"8625_CR40","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1128\/MCB.01693-13","volume":"34","author":"A Zafar","year":"2014","unstructured":"Zafar A, Wu F, Hardy K, Li J, Tu WJ, McCuaig R, et al. Chromatinized protein kinase C-\u03b8 directly regulates inducible genes in epithelial to mesenchymal transition and breast cancer stem cells. Mol Cell Biol. 2014;34:2961\u201380.","journal-title":"Mol Cell Biol"},{"key":"8625_CR41","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.biopha.2015.12.008","volume":"77","author":"S Kim","year":"2016","unstructured":"Kim S, Chun SY, Kwon YS, Nam KS. Crosstalk between Wnt signaling and Phorbol ester-mediated PKC signaling in MCF-7 human breast cancer cells. Biomed Pharmacother. 2016;77:114\u20139.","journal-title":"Biomed Pharmacother"},{"key":"8625_CR42","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.tranon.2018.12.011","volume":"12","author":"AA Blanchard","year":"2019","unstructured":"Blanchard AA, Ma X, Wang N, Hombach-Klonisch S, Penner C, Ozturk A, et al. Claudin 1 is highly upregulated by PKC in MCF7 human breast cancer cells and correlates positively with PKC\u03b5 in patient biopsies. Transl Oncol. 2019;12:561\u201375.","journal-title":"Transl Oncol"},{"key":"8625_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-023-00604-4","volume":"9","author":"L Beumers","year":"2023","unstructured":"Beumers L, Vlachavas EI, Borgoni S, Schwarzm\u00fcller L, Penso-Dolfin L, Michels BE, et al. Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets. NPJ Breast Cancer. 2023;9:97.","journal-title":"NPJ Breast Cancer"},{"key":"8625_CR44","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/jcmm.14024","volume":"23","author":"M Jiang","year":"2019","unstructured":"Jiang M, Yan Y, Yang K, Liu Z, Qi J, Zhou H, et al. Small molecule nAS-E targeting cAMP response element binding protein (CREB) and CREB-binding protein interaction inhibits breast cancer bone metastasis. J Cell Mol Med. 2019;23:1224\u201334.","journal-title":"J Cell Mol Med"},{"key":"8625_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04640-3","volume":"21","author":"Y Ding","year":"2023","unstructured":"Ding Y, Huang Y, Zhang F, Gong L, Liang C, Ding K, et al. LncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p\/CREB1 axis. J Transl Med. 2023;21:854.","journal-title":"J Transl Med"},{"key":"8625_CR46","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12931-023-02567-3","volume":"24","author":"G Shan","year":"2023","unstructured":"Shan G, Bi G, Zhao G, Liang J, Bian Y, Zhang H, et al. Inhibition of the PKA\/CREB1 pathway confers sensitivity to ferroptosis in non-small cell lung cancer. Respir Res. 2023;24:277.","journal-title":"Respir Res"},{"key":"8625_CR47","doi-asserted-by":"publisher","first-page":"29025","DOI":"10.1002\/jmv.29025","volume":"95","author":"Y Li","year":"2023","unstructured":"Li Y, Patterson MR, Morgan EL, Wasson CW, Ryder EL, Barba-Moreno D, et al. CREB1 activation promotes human papillomavirus oncogene expression and cervical cancer cell transformation. J Med Virol. 2023;95:29025.","journal-title":"J Med Virol"},{"key":"8625_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.795","volume":"12","author":"D Tewari","year":"2022","unstructured":"Tewari D, Priya A, Bishayee A, Bishayee A. Targeting transforming growth factor-\u03b2 signalling for cancer prevention and intervention: Recent advances in developing small molecules of natural origin. Clin Transl Med. 2022;12:795.","journal-title":"Clin Transl Med"},{"key":"8625_CR49","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2853","volume":"10","author":"H Ikushima","year":"2010","unstructured":"Ikushima H, Miyazono K. TGFbeta signalling: a complex web in cancer progression. Nat Rev Cancer. 2010;10:415\u201324.","journal-title":"Nat Rev Cancer"},{"key":"8625_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-019-1068-7","volume":"19","author":"L Wang","year":"2019","unstructured":"Wang L, Xu C, Liu X, Yang Y, Cao L, Xiang G, et al. TGF-\u03b21 stimulates epithelial-mesenchymal transition and cancer-associated myoepithelial cells during the progression from in situ to invasive breast cancer. Cancer Cell Int. 2019;19:343.","journal-title":"Cancer Cell Int"},{"key":"8625_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-016-0698-0","volume":"18","author":"F Zhang","year":"2016","unstructured":"Zhang F, Dong W, Zeng W, Zhang L, Zhang C, Qiu Y, et al. Naringenin prevents TGF-\u03b21 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation. Breast Cancer Res. 2016;18:38.","journal-title":"Breast Cancer Res"},{"key":"8625_CR52","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41420-024-01910-x","volume":"10","author":"A Affinito","year":"2024","unstructured":"Affinito A, Quintavalle C, Chianese RV, Roscigno G, Fiore D, D'Argenio V, et al. MCT4-driven CAFs-mediated metabolic reprogramming in the breast cancer microenvironment is a vulnerability targetable by miR-425-5p. Cell Death Discov. 2024;10:140.","journal-title":"Cell Death Discov"},{"key":"8625_CR53","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.canlet.2018.10.015","volume":"442","author":"S Wen","year":"2019","unstructured":"Wen S, Hou Y, Fu L, Xi L, Yang D, Zhao M, et al. Cancer-associated fibroblast (CAFs)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin \u03b23-p38 MAPK signalling. Cancer Lett. 2019;442:320\u201332.","journal-title":"Cancer Lett"},{"key":"8625_CR54","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.canlet.2019.02.044","volume":"452","author":"X Tang","year":"2019","unstructured":"Tang X, Tu G, Yang G, Wang X, Kang L, Yang L, et al. Autocrine TGF-\u03b21\/miR-200s\/miR-221\/DNMT3B regulatory loop maintains CAFs status to fuel breast cancer cell proliferation. Cancer Lett. 2019;452:79\u201389.","journal-title":"Cancer Lett"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08625-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08625-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08625-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:02:59Z","timestamp":1774987379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08625-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8625"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08625-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"2 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"327"}}